Dicerna Pharmaceuticals, Inc. (DRNA) Social Stream



Dicerna Pharmaceuticals, Inc. (DRNA): $20.82

-0.79 (-3.66%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DRNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 503

in industry

Dicerna Pharmaceuticals Inc (DRNA) Price Targets From Analysts

Use the tables below to see what analysts covering Dicerna Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
9 $35 $26 $30.89 $21.61 42.94%

The Trend in the Analyst Price Target


DRNA's average price target has moved down $4.11 over the prior 41 weeks.

Over the past 15 months, DRNA's average upside potential has been 37.53%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 9 35 26 30.89 21.70 42.35%
2021-09-04 9 35 26 30.89 21.24 45.43%
2021-08-28 9 35 26 30.89 20.65 49.59%
2021-08-09 9 49 30 37.22 23.83 56.19%
2021-08-07 9 49 30 37.44 27.25 37.39%
2021-08-05 9 54 34 42.00 37.92 10.76%
2021-08-01 9 54 34 42.00 37.51 11.97%
2021-07-24 9 54 34 42.00 37.51 11.97%
2021-07-17 9 54 34 42.00 38.00 10.53%
2021-07-10 9 54 34 42.00 38.04 10.41%
2021-07-03 9 54 34 42.00 37.77 11.2%
2021-06-21 9 54 34 40.78 37.43 8.95%
2021-06-13 9 54 34 40.78 37.36 9.15%
2021-06-05 9 48 34 39.67 31.10 27.56%
2021-04-26 9 48 34 39.56 29.37 34.7%
2021-04-25 9 48 34 39.56 28.68 37.94%
2021-04-17 9 48 34 38.44 28.96 32.73%
2021-03-23 8 45 34 37.38 24.33 53.64%
2021-03-20 8 45 34 37.38 26.06 43.44%
2021-03-13 8 45 34 37.38 27.80 34.46%
2021-03-05 8 45 34 37.38 27.40 36.42%
2021-02-01 8 45 25 34.63 22.81 51.82%
2021-01-30 8 45 25 34.63 22.47 54.12%
2021-01-23 9 45 25 35.78 24.64 45.21%
2021-01-16 9 45 25 35.78 23.57 51.8%
2021-01-09 9 45 25 35.00 23.29 50.28%
2021-01-02 9 45 25 35.00 22.03 58.87%
2020-11-26 9 45 25 35.00 23.37 49.76%
2020-11-23 9 45 25 35.00 22.86 53.11%
2020-11-09 9 48 25 35.33 22.03 60.37%
2020-10-26 9 48 25 34.78 20.32 71.16%
2020-08-19 9 46 25 34.56 NA NA%
2020-08-12 9 46 25 34.56 NA NA%
2020-08-06 9 46 25 34.44 NA NA%
2020-07-25 9 45 25 33.78 NA NA%
2020-06-20 9 45 25 33.78 NA NA%
2020-06-05 9 45 25 33.78 NA NA%

DRNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.59 2 5 4 0 0 11

The Trend in the Broker Recommendations


DRNA's average broker recommendation rating worsened by 1.08 over the prior 48 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The number of analysts covering the stock of DRNA is greater than 69.83% of all US stocks.
  • DRNA has a higher upside potential (average analyst target price relative to current price) than 79.17% of stocks in the mid market cap category.
  • DRNA has a less variance in analysts' estimates than 65.64% of Pharmaceutical Products stocks.
  • Dicerna Pharmaceuticals Inc's average analyst price target is greater than 63.39% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, RPRX, BHC and SGMO are the three stocks most similar to Dicerna Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding DRNA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7879 seconds.